Status:
RECRUITING
GCS Survey: "GHB IN CHEMICAL SUBMISSION: MYTH OR REALITY?"
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Mission Interministérielle de Lutte contre les Drogues et les Conduites Addictives - MILDECA
Conditions:
CHEMICAL SUBMISSION
Eligibility:
All Genders
18+ years
Brief Summary
According to the media, GHB is the main substance used for chemical submission. The national survey conducted by the Addictovigilance centre of Paris on drug-facilitated assaults shows that GHB is use...
Detailed Description
The Addictovigilance center of Paris (CEIP-A) has been responsible for the national chemical submission survey under the supervision of the French National Agency for the Safety of Medicines and Healt...
Eligibility Criteria
Inclusion
- Victims over the age of majority (≥ 18 years) on the day of the alleged events
- With a medical history leading to the suspicion of chemical submission:
- Presence of evocative clinical signs (amnesia and/or behavioural disorders and/or neurological disorders and/or other somatic disorders, etc.) AND
- In the presence of potential criminal acts (suspected or proven assault or attempted assault).
- French speaking
- Having been informed of the search
Exclusion
- \- Victims who were minors (\<18 years) on the day of the alleged events.
- Victims who usually use GHB/GBL recreationally.
- Suspecting administration of a harmful substance with no crime or offence committed at the time and no attempted assault
- Victims of needle spiking
- Victims with very short hair (\<3 cm), bald or shaven heads
- Victims who have exceeded the maximum time limit for taking a hair sample (6 months after the event)
- Do not speak French
- Oppose to participating in the study
- Victims presenting a psychotic or cognitive syndrome likely to impair judgement Victims placed under guardianship or legal protection (article L11-22-2 CSP)
Key Trial Info
Start Date :
March 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 20 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06137599
Start Date
March 20 2024
End Date
March 20 2026
Last Update
July 3 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Laetitia LASNE
Bondy, France, 93140
2
Elisabeth ALCARAZ
Paris, France, 75004
3
Leila CHAOUACHI
Paris, France, 75010